Xia Xia

Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)

Chu-Tse Wu, Gangqiao Zhou, Zun-en Xia, 2020, Trials.

A phase I, single and continuous dose administration study on the safety, tolerability, and pharmacokinetics of neorudin, a novel recombinant anticoagulant protein, in healthy subjects

Chu-Tse Wu, Xiaona Dong, Lin Zhang, 2021, Pharmacology research & perspectives.